CSI Market
Sign In | Register

Inmune Bio Inc (INMB) Annual Balance Sheets

Annual · GAAP · USD millions
Access INMB quarterly Balance Sheets →
Balance sheet data covering Inmune Bio Inc–Dec 31 2021 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent24.75
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments24.00
Accounts receivable4.28
Other Receivables, Net, Current0.26
Value Added Tax Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.60
Total Current Assets29.89
Equipment/Property/Plant Net0.96
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.51
Research And Development Tax Credit Receivable-
Prepaid Expenses Related Party-
Operating Lease Right Of Use Asset0.91
Total Assets32.35
Liabilities
Accounts Payable and Accrued Liabilities, Current LI7.77
Accrued Liabilities And Other Liabilities0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.65
Total Current Liabilities8.42
Long-term debt0.00
Capital Lease and Other0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.41
OperatingLeaseLiabilityNoncurrent0.41
Operating Lease Liability Current0.62
Total Liabilities8.83
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock233.27
Retained Earnings / Accumulated Deficit-209.04
Accumulated Other Comprehensive Income0.00
Other Equity-0.74
Common Stockholder's Equity23.52
Non-controlling interests & other0.00
Total Stockholder's Equity23.52
Liabilities & Stockholder's Equity32.35
4 historic quarters locked

Sign in to unlock the full Inmune Bio Inc balance sheet history.

Sign In Create Free Account

About Inmune Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-036370

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.